Douglas Earl Martin Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$10,950.84

Insider Activity of Douglas Earl Martin

According to the SEC Form 4 filings, Douglas Earl Martin, being in a position of

  1. SVP, General Counsel at Allogene Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 52597 shares for $103,262,
    over all time since 2025-02-03, has bought 0 shares, and sold 59001 share for $114,212.

Biography of Douglas Earl Martin

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $103,2622100

Comparison of Insiders on Amount of Buys and Sells

2026-08-21SaleAllogene Therapeutics, Inc.
ALLO
SVP, General Counsel
29,697
0.0092%
$2.12$62,958-22.49%
2026-02-02SaleAllogene Therapeutics, Inc.
ALLO
SVP, General Counsel
22,900
0.0096%
$1.76$40,304+8.29%
2025-02-03SaleAllogene Therapeutics, Inc.
ALLO
SVP, General Counsel
6,404
0.0029%
$1.71$10,951-19.16%
Total: 3
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.